Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 842–843 | Cite as

ASO Author Reflections: R0 Resection and Targeted Therapy for Colorectal Peritoneal Metastasis

  • Dai ShidaEmail author
ASO Author Reflections



The author has no conflicts of interest to disclose.


  1. 1.
    Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomized trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 2016;17(12):1709–19.CrossRefGoogle Scholar
  2. 2.
    Shida D, Tsukamoto S, Ochiai H, Kanemitsu Y. Long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25(1):173–8.CrossRefGoogle Scholar
  3. 3.
    Shida D, Yoshida T, Tanabe T, Tsukamoto S, Ochiai H, Kanemitsu Y. Prognostic impact of R0 resection and targeted therapy for colorectal cancer with synchronous peritoneal metastasis. Ann Surg Oncol. 2018;25(6):1646–53.CrossRefGoogle Scholar
  4. 4.
    UICC. TNM classification of malignant tumours. 8th ed. New York: Wiley; 2017.Google Scholar
  5. 5.
    Benson AB 3rd, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2017;15(3):370–98.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Colorectal Surgery DivisionNational Cancer Center HospitalTokyoJapan

Personalised recommendations